CASI Pharmaceuticals (CASI)

• Market cap: $18.6M
• 1 day: 0%
• 5 days: -9.77%
• 1 month: -32.58%
• 3 months: -47.37%
• 6 months: -35.83%
• Year to date: -59.73%
• 1 year: -77.19%
• 5 years: -94.57%
• 10 years: -89.29%
• Sector: Healthcare
• Industry: Biotechnology

About: CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Employees: 233